| Name | Title | Contact Details |
|---|---|---|
Frank Hudson |
Senior Vice President, R&D Finance | Profile |
Claudia Uchima |
Senior Director of Human Resources | Profile |
Judy Ball |
Acting Head of Talent Acquisition | Profile |
Jennifer Hersom |
Director of Talent and Organization Development | Profile |
Sean Penistone |
Senior Director - Learning and Development - Talent and Od | Profile |
University Cancer & Blood Center’s highly skilled medical professionals, whose backgrounds include working at the nation’s leading cancer centers, provide every patient with the...
RoslinCT is a UK-based Cell and Gene Therapy Contract Development and Manufacturing Organisation (CDMO) that provides services for companies developing cell and gene-based therapeutic products. They offer a range of integrated services from GMP transla...
Resolution Medical Overview Medical Device and Component Manufacturing, Development, Testing, and other Engineering Services.
Trevi Therapeutics, Inc. is a late-stage clinical development company developing Nalbuphine® ER for chronic pruritus (itch). Pruritus develops in various dermatologic, metabolic, hematologic, and neuropathic conditions. The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with significant impairment in quality of life and increased mortality. Prurigo nodularis is an intensely pruritic dermatologic condition characterized by unsightly and itchy skin papules and nodules. There are no approved therapies in the United States or Europe for either condition.
Caribbean Clinical Research ASsociates is a East Orange, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.